For the twelve months ended Jun 30, 2026, VivoSim Labs Inc. reported $112.0K of revenue and -$12.34M of net income.
VIVS revenue was $18.0K in fiscal Q1 2027 (ended Jun 30, 2026), down 51.4% from a year earlier and down 55.0% from the prior quarter. For the full fiscal 2026 it was $131.0K, down 9.0% from fiscal 2025. Compound annual growth was -21.5% over 10 years. It rose in 1 of the last 4 fiscal years.
VIVS net income was -$1.34M in fiscal Q1 2027 (ended Jun 30, 2026), compared with -$2.84M a year earlier. For the full fiscal 2026 it was -$13.84M, compared with -$2.49M in fiscal 2025.
VIVS diluted EPS was -$0.25 in fiscal Q1 2027 (ended Jun 30, 2026). For the full fiscal 2026 it was -$5.35.
VIVS free cash flow was -$3.24M in fiscal Q1 2027 (ended Jun 30, 2026), compared with -$3.94M a year earlier. For the full fiscal 2026 it was -$10.83M, compared with -$9.47M in fiscal 2025.
| Line item | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $131.0K | $144.0K | $109.0K | $370.0K | $1.50M | $0 | $2.20M | $3.09M | $4.60M | $4.23M |
| Cost of revenue | $0 | $5.0K | - | - | - | $0 | $300.0K | $500.0K | $1.00M | $956.0K |
| Gross profit | $131.0K | $139.0K | - | - | - | $0 | $1.90M | $2.59M | $3.60M | $3.27M |
| Research and development | $4.19M | $5.03M | $5.50M | $8.88M | $3.32M | $1.10M | $5.28M | $14.75M | $17.96M | $19.55M |
| Selling, general and admin | $7.43M | $7.73M | $9.70M | $9.22M | $9.66M | $15.72M | $18.06M | $15.13M | $20.89M | $22.30M |
| Operating income | -$11.49M | -$12.62M | -$15.09M | -$17.73M | -$11.48M | -$16.83M | -$21.48M | -$27.27M | -$35.27M | -$38.58M |
| Interest expense | $12.0K | $10.0K | - | - | - | - | - | - | - | $0 |
| Pre-tax income | -$13.84M | -$2.49M | - | - | - | - | - | - | - | - |
| Income tax | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $3.0K | $2.0K | $23.0K |
| Net income | -$13.84M | -$2.49M | -$14.67M | -$17.26M | -$11.45M | -$16.83M | -$18.71M | -$26.64M | -$34.80M | -$38.45M |
| EPS, basic | -$5.35 | -$1.70 | -$19.25 | -$23.76 | -$15.84 | -$29.28 | -$33.60 | -$55.20 | -$76.80 | -$93.60 |
| EPS, diluted | -$5.35 | -$1.70 | -$19.25 | -$23.76 | -$15.84 | -$29.28 | -$33.60 | -$55.20 | -$76.80 | -$93.60 |
| Diluted shares | 2.6M | 1.5M | 762,076 | 726,086 | 725,299.667 | 575,166.667 | 539,817.333 | 480,749.592 | 446,849.892 | 407,345.967 |
| Line item | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $5.02M | $11.31M | $2.90M | $15.30M | $28.68M | $37.36M | $27.36M | $36.48M | $43.73M | $62.75M |
| Short-term investments | - | - | - | - | $0 | - | - | - | - | - |
| Receivables | $32.0K | $30.0K | $33.0K | $152.0K | $0 | $0 | $111.0K | $503.0K | $883.0K | $647.0K |
| Inventory | - | $0 | $297.0K | $0 | - | - | $0 | $490.0K | $842.0K | $550.0K |
| Current assets | $6.63M | $12.13M | $3.94M | $17.05M | $29.53M | $38.40M | $28.32M | $38.57M | $46.76M | $65.09M |
| Total assets | $7.39M | $14.65M | $6.35M | $20.31M | $33.30M | $39.92M | $28.44M | $40.62M | $49.83M | $69.18M |
| Current liabilities | $2.79M | $3.74M | $1.86M | $3.67M | $1.38M | $721.0K | $1.81M | $3.74M | $4.66M | $6.01M |
| Total liabilities | $8.48M | $4.16M | $2.75M | $4.98M | $3.09M | $721.0K | $1.81M | $4.33M | $5.24M | $6.82M |
| Shareholders' equity | -$1.10M | $10.49M | $3.60M | $15.33M | $30.21M | $39.20M | $26.63M | $36.30M | $44.59M | $62.36M |
| Line item | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$10.83M | -$9.46M | -$14.65M | -$12.41M | -$8.45M | -$13.32M | -$14.88M | -$20.38M | -$28.86M | -$29.18M |
| Capital expenditures | $0 | $13.0K | $42.0K | $396.0K | $409.0K | $405.0K | $0 | $79.0K | $226.0K | $1.35M |
| Free cash flow | -$10.83M | -$9.47M | -$14.70M | -$12.80M | -$8.86M | -$13.73M | -$14.88M | -$20.45M | -$29.08M | -$30.54M |
| Investing cash flow | $94.0K | $9.03M | $816.0K | -$966.0K | -$409.0K | -$393.0K | $747.0K | -$76.0K | -$292.0K | -$1.39M |
| Financing cash flow | $4.45M | $8.85M | $1.44M | $0 | $205.0K | $23.84M | $4.93M | $13.15M | $10.11M | $31.25M |
| Share repurchases | - | - | - | - | $0 | $1.0K | $0 | - | - | - |
| Stock-based compensation | - | - | - | - | - | - | - | - | $6.90M | $7.39M |
| Depreciation and amortization | $215.0K | $266.0K | $280.0K | $293.0K | $142.0K | $41.0K | $1.14M | $980.0K | $1.27M | $1.15M |
| Line item | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | -9.0% | 32.1% | -70.5% | -75.3% | - | -100.0% | -29.0% | -32.8% | 8.8% | 185.2% |
| Gross margin | 100.0% | 96.5% | - | - | - | - | 86.3% | 83.8% | 78.3% | 77.4% |
| Operating margin | -8768.7% | -8761.1% | -13840.4% | -4792.2% | -765.3% | - | -977.9% | -882.4% | -766.3% | -911.9% |
| Net margin | -10567.2% | -1727.8% | -13459.6% | -4664.6% | -763.2% | - | -852.0% | -861.7% | -756.1% | -908.9% |
| Free cash flow margin | -8264.9% | -6579.2% | -13481.7% | -3460.5% | -590.8% | - | -677.7% | -661.7% | -631.8% | -722.0% |
| Return on equity | - | -23.7% | -407.4% | -112.6% | -37.9% | -42.9% | -70.3% | -73.4% | -78.1% | -61.7% |
| Return on assets | -187.4% | -17.0% | -231.1% | -85.0% | -34.4% | -42.2% | -65.8% | -65.6% | -69.8% | -55.6% |
| Current ratio | 2.38 | 3.25 | 2.12 | 4.64 | 21.35 | 53.26 | 15.65 | 10.32 | 10.04 | 10.83 |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $18.0K | $40.0K | $26.0K | $28.0K | $37.0K | $51.0K | $24.0K | $30.0K | $39.0K | $29.0K | $5.0K | $0 |
| Cost of revenue | - | $0 | $0 | $0 | $0 | $0 | $2.0K | $1.0K | $2.0K | - | $0 | $0 |
| Gross profit | - | $40.0K | $26.0K | $28.0K | $37.0K | $51.0K | $22.0K | $29.0K | $37.0K | - | $5.0K | $0 |
| Research and development | $1.13M | $1.13M | $1.14M | $923.0K | $1.00M | $859.0K | $1.78M | $984.0K | $1.40M | $1.06M | $1.43M | $1.33M |
| Selling, general and admin | $1.65M | $2.10M | $1.64M | $1.74M | $1.95M | $2.35M | $1.71M | $1.65M | $2.02M | $2.06M | $2.25M | $2.78M |
| Operating income | -$2.76M | -$3.19M | -$2.75M | -$2.63M | -$2.92M | -$3.15M | -$3.47M | -$2.61M | -$3.39M | -$3.10M | -$3.68M | -$4.12M |
| Interest expense | $4.0K | $4.0K | $4.0K | $0 | $4.0K | $5.0K | $5.0K | $0 | $0 | - | $0 | - |
| Income tax | $3.0K | $0 | $0 | $2.0K | $0 | $0 | $0 | $0 | $2.0K | $0 | $0 | $0 |
| Net income | -$1.34M | -$5.76M | -$2.69M | -$2.54M | -$2.84M | $6.85M | -$3.45M | -$2.55M | -$3.34M | -$3.04M | -$3.60M | -$3.99M |
| EPS, basic | -$0.25 | -$2.20 | -$1.03 | -$0.98 | -$1.14 | - | -$2.28 | -$1.68 | -$2.74 | -$3.41 | -$4.80 | -$5.52 |
| EPS, diluted | -$0.25 | -$2.20 | -$1.03 | -$0.98 | -$1.14 | - | -$2.28 | -$1.68 | -$2.74 | -$3.41 | -$4.80 | -$5.52 |
| Diluted shares | 5.2M | - | 2.6M | 2.6M | 2.5M | - | 1.5M | 1.5M | 1.2M | - | 759,621.25 | 726,541.833 |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $1.67M | $5.02M | $4.29M | $6.68M | $9.05M | $11.31M | $1.16M | $3.17M | $6.19M | $2.90M | $5.29M | $7.62M |
| Receivables | $29.0K | $32.0K | $33.0K | $32.0K | $32.0K | $30.0K | $26.0K | $29.0K | $48.0K | $33.0K | $33.0K | $55.0K |
| Inventory | - | - | - | - | - | $0 | $0 | $640.0K | $408.0K | $297.0K | - | - |
| Current assets | $3.23M | $6.63M | $6.04M | $7.59M | $9.68M | $12.13M | $2.10M | $4.78M | $7.28M | $3.94M | $6.24M | $8.30M |
| Total assets | $3.85M | $7.39M | $6.96M | $9.69M | $11.98M | $14.65M | $3.84M | $6.75M | $9.47M | $6.35M | $8.88M | $11.16M |
| Current liabilities | $1.89M | $2.79M | $2.48M | $2.45M | $2.14M | $3.74M | $2.94M | $2.41M | $2.03M | $1.86M | $1.70M | $1.60M |
| Total liabilities | $6.19M | $8.48M | $2.52M | $2.62M | $2.44M | $4.16M | $3.48M | $3.07M | $2.81M | $2.75M | $2.70M | $2.71M |
| Shareholders' equity | -$2.35M | -$1.10M | $4.44M | $7.07M | $9.54M | $10.49M | $364.0K | $3.68M | $6.66M | $3.60M | $6.18M | $8.46M |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$3.21M | -$2.24M | -$2.27M | -$2.38M | -$3.94M | -$2.04M | -$1.80M | -$2.64M | -$2.98M | -$2.67M | -$3.52M | -$3.15M |
| Capital expenditures | $23.0K | $0 | $0 | $0 | $0 | $0 | $0 | $13.0K | $0 | $0 | $0 | $27.0K |
| Free cash flow | -$3.24M | -$2.24M | -$2.27M | -$2.38M | -$3.94M | -$2.04M | -$1.80M | -$2.65M | -$2.98M | -$2.67M | -$3.52M | -$3.18M |
| Investing cash flow | -$23.0K | $94.0K | $0 | $0 | $0 | $9.00M | $4.0K | $0 | $20.0K | $13.0K | $27.0K | $12.0K |
| Financing cash flow | -$118.0K | $2.88M | -$118.0K | $0 | $1.68M | $3.19M | -$216.0K | -$371.0K | $6.25M | $264.0K | $1.17M | $0 |
| Depreciation and amortization | $40.0K | $43.0K | $52.0K | $59.0K | $61.0K | $61.0K | $67.0K | $68.0K | $70.0K | $71.0K | $71.0K | $71.0K |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | -51.4% | -21.6% | 8.3% | -6.7% | -5.1% | 75.9% | 380.0% | - | -48.0% | -82.1% | -96.2% | -100.0% |
| Gross margin | - | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 91.7% | 96.7% | 94.9% | - | 100.0% | - |
| Operating margin | -15327.8% | -7967.5% | -10576.9% | -9410.7% | -7878.4% | -6184.3% | -14450.0% | -8693.3% | -8682.1% | -10675.9% | -73600.0% | - |
| Net margin | -7433.3% | -14410.0% | -10350.0% | -9089.3% | -7683.8% | 13435.3% | -14362.5% | -8496.7% | -8574.4% | -10500.0% | -72080.0% | - |
| Free cash flow margin | -17977.8% | -5595.0% | -8734.6% | -8492.9% | -10648.6% | -3990.2% | -7504.2% | -8850.0% | -7648.7% | -9210.3% | -70440.0% | - |
| Current ratio | 1.70 | 2.38 | 2.44 | 3.10 | 4.52 | 3.25 | 0.72 | 1.98 | 3.58 | 2.12 | 3.67 | 5.18 |
Source: XBRL data VivoSim Labs Inc. files with the SEC, latest filing dated Aug 12, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures and share counts are restated for stock splits the filings show: 1-for-20, first reported Nov 5, 2020; 1-for-12, first reported Jun 5, 2025.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| VIVS | $112.0K | -21.1% | -$12.34M | -11016.1% | $2.2M |
| AMGN | $38.90B | +8.2% | $9.39B | 24.1% | $249.05B |
| GILD | $30.99B | +6.5% | -$3.86B | -12.5% | $207.00B |
| MRNA | $2.52B | +13.1% | -$2.79B | -110.5% | $101.48B |
| ARGX | $4.25B | +88.6% | $1.29B | 30.4% | $57.55B |
| RVMD | $0 | - | -$1.13B | - | $41.59B |
| BIIB | $10.30B | +2.3% | $347.50M | 3.4% | $36.71B |
| BNTX | €2.87B | +4.3% | -€1.14B | -39.6% | $21.98B |
| EXEL | $2.50B | +9.1% | $885.14M | 35.5% | $16.98B |